Tenley C. Archer

2.6k total citations
17 papers, 772 citations indexed

About

Tenley C. Archer is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Tenley C. Archer has authored 17 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Tenley C. Archer's work include Glioma Diagnosis and Treatment (5 papers), Chromatin Remodeling and Cancer (4 papers) and Hedgehog Signaling Pathway Studies (3 papers). Tenley C. Archer is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Chromatin Remodeling and Cancer (4 papers) and Hedgehog Signaling Pathway Studies (3 papers). Tenley C. Archer collaborates with scholars based in United States, Germany and Switzerland. Tenley C. Archer's co-authors include Scott L. Pomeroy, Elena Silva Casey, Jing Jin, Crystal D. Rogers, Shyamal Dilhan Weeraratne, Emma C. Troisi, Su Wang, Xiaofeng Wang, Shawn Gillespie and B. Alver and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Tenley C. Archer

17 papers receiving 763 citations

Peers

Tenley C. Archer
Sandeep N. Shah United States
Kanae Mitsunaga Japan
Daniel Rosebrock United States
Ahmet Kurdoglu United States
Sean Tsao United States
Tihomira I. Todorova United States
Kara M. Foshay United States
Eli S. Williams United States
Manuel Buscarlet Canada
Romain Daveau France
Sandeep N. Shah United States
Tenley C. Archer
Citations per year, relative to Tenley C. Archer Tenley C. Archer (= 1×) peers Sandeep N. Shah

Countries citing papers authored by Tenley C. Archer

Since Specialization
Citations

This map shows the geographic impact of Tenley C. Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tenley C. Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tenley C. Archer more than expected).

Fields of papers citing papers by Tenley C. Archer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tenley C. Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tenley C. Archer. The network helps show where Tenley C. Archer may publish in the future.

Co-authorship network of co-authors of Tenley C. Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Tenley C. Archer. A scholar is included among the top collaborators of Tenley C. Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tenley C. Archer. Tenley C. Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Trovão, Nídia S., et al.. (2022). COVID-19 Exposure Assessment Tool (CEAT): Exposure quantification based on ventilation, infection prevalence, group characteristics, and behavior. Science Advances. 8(39). eabq0593–eabq0593. 12 indexed citations
2.
Law, Brian K., Tenley C. Archer, Daniel Lu, et al.. (2022). Bmf-500: An Orally Bioavailable Covalent Inhibitor of FLT3 with High Selectivity and Potent Antileukemic Activity in FLT3-Mutated AML. Blood. 140(Supplement 1). 6191–6192. 3 indexed citations
3.
Lu, Daniel, et al.. (2022). Preclinical activity of irreversible Menin inhibitor, BMF-219, in chronic lymphocytic leukemia.. Journal of Clinical Oncology. 40(16_suppl). 7541–7541. 2 indexed citations
4.
Poore, Brad, Allison R. Hanaford, Khoa Pham, et al.. (2021). TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters. 504. 137–145. 5 indexed citations
5.
Lu, Daniel, Brian K. Law, Tenley C. Archer, et al.. (2021). Novel Irreversible Menin Inhibitor, BMF-219, Shows Potent Single Agent Activity in Clinically Relevant DLBCL Cells. Blood. 138(Supplement 1). 4318–4318. 2 indexed citations
6.
Archer, Tenley C., Soma Sengupta, & Scott L. Pomeroy. (2018). Brain cancer genomics and epigenomics. Handbook of clinical neurology. 148. 785–797. 5 indexed citations
7.
Boulay, Gaylor, Mary E. Awad, Nicolò Riggi, et al.. (2017). OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Cancer Discovery. 7(3). 288–301. 50 indexed citations
8.
Archer, Tenley C., et al.. (2017). Medulloblastoma: Molecular Classification-Based Personal Therapeutics. Neurotherapeutics. 14(2). 265–273. 67 indexed citations
9.
Wang, Xiaofeng, Ryan S. Lee, B. Alver, et al.. (2016). SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation. Nature Genetics. 49(2). 289–295. 239 indexed citations
10.
Archer, Tenley C., Elana J. Fertig, Sara J.C. Gosline, et al.. (2016). Systems Approaches to Cancer Biology. Cancer Research. 76(23). 6774–6777. 19 indexed citations
11.
Weeraratne, Shyamal Dilhan, Vladimir Amani, Natalia Teider, et al.. (2012). Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathologica. 123(4). 539–552. 128 indexed citations
12.
Archer, Tenley C. & Scott L. Pomeroy. (2012). Medulloblastoma Biology in the Post-Genomic Era. Future Oncology. 8(12). 1597–1604. 6 indexed citations
13.
Pugh, Trevor J., Yoon‐Jae Cho, Tenley C. Archer, et al.. (2012). Abstract 4868: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations within a wide spectrum of genetic heterogeneity. Cancer Research. 72(8_Supplement). 4868–4868. 1 indexed citations
14.
Archer, Tenley C., Shyamal Dilhan Weeraratne, & Scott L. Pomeroy. (2012). Hedgehog-GLI Pathway in Medulloblastoma. Journal of Clinical Oncology. 30(17). 2154–2156. 29 indexed citations
15.
Archer, Tenley C., Jing Jin, & Elena Silva Casey. (2010). Interaction of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis. Developmental Biology. 350(2). 429–440. 97 indexed citations
16.
17.
Rogers, Crystal D., et al.. (2007). Sox3 expression is maintained by FGF signaling and restricted to the neural plate by Vent proteins in the Xenopus embryo. Developmental Biology. 313(1). 307–319. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandeep N. Shah Breakdown of academic impact, for papers by Kanae Mitsunaga Breakdown of academic impact, for papers by Daniel Rosebrock Breakdown of academic impact, for papers by Ahmet Kurdoglu Breakdown of academic impact, for papers by Sean Tsao Breakdown of academic impact, for papers by Tihomira I. Todorova Breakdown of academic impact, for papers by Kara M. Foshay Breakdown of academic impact, for papers by Eli S. Williams Breakdown of academic impact, for papers by Manuel Buscarlet Breakdown of academic impact, for papers by Romain Daveau
Rankless by CCL
2026